1. Home
  2. SLNG vs APLT Comparison

SLNG vs APLT Comparison

Compare SLNG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNG
  • APLT
  • Stock Information
  • Founded
  • SLNG 2013
  • APLT 2016
  • Country
  • SLNG United States
  • APLT United States
  • Employees
  • SLNG N/A
  • APLT N/A
  • Industry
  • SLNG Oil/Gas Transmission
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLNG Utilities
  • APLT Health Care
  • Exchange
  • SLNG Nasdaq
  • APLT Nasdaq
  • Market Cap
  • SLNG 85.4M
  • APLT 80.3M
  • IPO Year
  • SLNG N/A
  • APLT 2019
  • Fundamental
  • Price
  • SLNG $6.16
  • APLT $0.61
  • Analyst Decision
  • SLNG
  • APLT Buy
  • Analyst Count
  • SLNG 0
  • APLT 7
  • Target Price
  • SLNG N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • SLNG 22.2K
  • APLT 5.8M
  • Earning Date
  • SLNG 03-05-2025
  • APLT 03-05-2025
  • Dividend Yield
  • SLNG N/A
  • APLT N/A
  • EPS Growth
  • SLNG N/A
  • APLT N/A
  • EPS
  • SLNG 0.21
  • APLT N/A
  • Revenue
  • SLNG $74,044,000.00
  • APLT N/A
  • Revenue This Year
  • SLNG N/A
  • APLT N/A
  • Revenue Next Year
  • SLNG N/A
  • APLT $2,622.90
  • P/E Ratio
  • SLNG $29.32
  • APLT N/A
  • Revenue Growth
  • SLNG N/A
  • APLT N/A
  • 52 Week Low
  • SLNG $3.77
  • APLT $0.54
  • 52 Week High
  • SLNG $7.93
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • SLNG 44.73
  • APLT 27.09
  • Support Level
  • SLNG $5.64
  • APLT $0.54
  • Resistance Level
  • SLNG $7.79
  • APLT $0.64
  • Average True Range (ATR)
  • SLNG 0.63
  • APLT 0.07
  • MACD
  • SLNG -0.14
  • APLT 0.12
  • Stochastic Oscillator
  • SLNG 22.71
  • APLT 31.65

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: